Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PI Industries Ltd. Capital/Financing Update 2020

Sep 14, 2020

14931_rns_2020-09-14_207853d7-82a9-47d7-b65e-11ff184e1e6c.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

14th September, 2020 Gurugram

National Stock Exchange of India Ltd.,
Exchange Plaza, Plot No. C/1, G-Biock,
Bandra Kurla Complex, Bandra (East)
MUMBAI - 400 051
Code No. PIIND

Sub: Intimation of Incorporation of 2 Wholly-owned Subsidiary Company (WOS) - PI Enzachem Private Limited and PI Fermachem Private Limited

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

Dear Sirs,

Further to our letter dated August 04, 2020, wherein we had informed that Board of Directors approved the formation of two wholly owned subsidiary for carrying out pharma activities, we would like to inform the exchange that PI Industries Limited has incorporated two wholly owned subsidiary Companies namely;

    1. PI Enzachem Private Limited (CIN No. U24290RJ2020PTC070948} on September 11, 2020 vide certificate of incorporation granted by Central Registration Centre.
    1. PI Fermachem Private Limited (CIN No. U24233RJ2020PTC070968} on September 11, 2020 of incorporation granted by Central Registration Centre.

Intimations for same have been received by the company on September 12, 2020.

The details as required to be furnished under SEBI (LODR} Regulations, 2015 read with SEBI circular no. CIR/CFD/CMD/4/2015 dated September 09, 2015 are furnished in Annexure A forming part of this letter.

PI Industries ltd.

Corporate Off.: 5th Floor, Vipul Square, B-Biock, Sushant Lok Phase-1, Gurugram - 122009, Haryana (India), Tel. : +91124 6790000, Fax: +91124 4081247 Regd. Off.: Udaisagar Road, Udaipur-313001, Rajasthan (India) Tel.: +91 294 2492451-55, Fax: +91 294 2491946, 2491384 Email: [email protected], www.piindustries.com, CIN: L24211RJ1946PLC000469

Annexure A

Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

a) ofNamethetargetentity,detailsinbriefsuchturnoversize,asetc.; PI Enzachem Private Limited, a newWholly Owned Subsidiary formed by PIIndustries Ltd, having an authorisedshare capital of Rs. 10,00,000/-dividedin to 1,00,000 equity shares of Rs. 10/-each. PI Fermachem Private Limited, a newWholly Owned Subsidiary formed by PIIndustries Ltd, having an authorisedshare capital of Rs. 10,00,000/-dividedin to 1,00,000 equity shares of Rs. 10/-each.
Turnover & Net Profit: Not Applicableas newly incorporated entity. Turnover & Net Profit: Not Applicableas newly incorporated entity.
b) Whether the acquisitionwould fall within relatedparty transaction(s) andwhether the promoter/promoter group/ groupcompanieshaveanyinterestintheentitybeing acquired? If yes,nature of interestandthereofdetailsandwhether the same is doneat "arms-length"; Not Applicable, as company is a newlyincorporated Wholly Owned Subsidiaryof PI Industries Ltd. Not Applicable, as company is a newlyincorporated Wholly Owned Subsidiaryof PI Industries Ltd.
c) Industry to whichtheentitybeingacquiredbelongs; Pharma activities Pharma activities
d) effects ofObjects andacquisition {including butnot limited to, disclosureof reasons for acquisitionif itsof target entity,business is outside themain line of business ofthe listed entity); To carry on in India or anywhere in theworld, the business of manufacturing,developing, producing, buying, selling,importing, exporting, trading (online ooffline),agency,testing,· distributing,consigning,stocking,registering,packing, marketing, refining, processingof and generally dealing in all types of(a)chemicals,pharmaceuticals,biopharmaceuticals,biotherapeutics,biochemicals, patent medicines, drugs,materials and supplements, ophthalmicofproducts,alltypesactivepharmaceuticalingredients(API},biological products, medicinal products,4ilil ~ To carry on in India or anywhere in theworld, the business of manufacturing,developing, producing, buying, selling,importing, exporting, trading (online oroffline),agency,testing,distributing,consigning,stocking,registering,packing, marketing, refining, processingof and generally dealing in all types of(a)chemicals,pharmaceuticals,biopharmaceuticals,biotherapeutics,biochemicals, patent medicines, drugs,materials and supplements, ophthalmicofproducts,alltypesactivepharmaceuticalingredients{API},biological products, medicinal products,
thereof andproductstobetherefrom; over the counter drugs and products, over the counter drugs and products,biosimilars, derivatives and by products biosimilars, derivatives and by productsmade thereofandproductstobemadetherefrom;
(b)healthcare,nutrition,dietary,wellness, food, dairy, personal hygieneand other products for health, beautyand cosmetic purposes. (b)healthcare,nutrition,dietary,wellness, food, dairy, personal hygieneand other products for health, beautyand cosmetic purposes.
ofBriefdetailsanye)governmentalorregulatoryapprovalsrequiredfortheacquisition; Not Applicable Not Applicable
Indicative time period forf)ofcompletiontheacquisition; NotApplicable,entityasisincorporated on September 11, 2020. NotApplicable,entityisasincorporated on September 11, 2020.
ofNatureg)consideration-whethercashconsiderationor shareswap and details of the Subscription in cash by the Company100% along with individual subscriberbeing nominee of the Company. Subscription in cash by the Company -100% along with individual subscriberbeing nominee of the Company.
of acquisitionorh)Costthe price at which theshares are acquired; The Company has subscribed 10,000equity shares of PI Enzachem PrivateLimited at the face value of Rs. 10/-eachat a total consideration of Rs. 1,00,000/-. The Company has subscribed 10,000equity shares of PI Fermachem PrivateLimited at the face value of Rs. 10/-eachat a total consideration of Rs. 1,00,000/-.
ofi)PercentageIshareholdingcontrolacquired and I or numberof shares acquired; PI Enzachem Private Limited is a wholly PIowned subsidiary of PI Industries Ltd. whollywith an initial subscription of 10,000 Industriesof10/-equitysharesRs.aggregating to Rs. 1,00,000/-(Rupees Rs.One lacs Only). Fermachem Private Limited is aofownedsubsidiaryPILtd.withaninitialeach subscription of 10,000 equity shares ofto10/-eachaggregatingRs.1,00,000/- (Rupees One lacs Only).
j)Brief background abouttheentity acquiredinterms of products/line ofbusiness acquired, date ofincorporation, history oflast3yearsturnover,countryinwhichtheacquiredentityhaspresence and any othersignificant information (inbrief); Not Applicable Not Applicable